The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine

NCT05284851 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
2520
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Changchun BCHT Biotechnology Co.

Collaborators